Your trusted source for investing success

Tag: European Union

DelMar Pharmaceuticals Collaborates with Duke University to Explore VAL-083 as a Front-Line Treatment for Glioblastoma Multiforme

DelMar Pharmaceuticals Collaborates with Duke University to Explore VAL-083 as a Front-Line Treatment for Glioblastoma Multiforme

DelMar Pharmaceuticals (NASDAQ:DMPI), a biopharmaceutical company focused on the development and commercialization of new cancer therapies, today announced that it has entered into a three-year collaboration with Duke University to evaluate VAL-083, the Company’s platform compound, as a front-line treatment for newly diagnosed patients with glioblastoma multiforme (“GBM”).

MGX Acquires Additional 4,718 Claims at Paradox Basin

MGX Acquires Additional 4,718 Claims at Paradox Basin

MGX Minerals (CSE:XMG) has provided a project development update for its Paradox basin petrolithium project.

The company has begun unitization of designated oil and gas leases and the staking of overlying mineral claims located contiguous to its Lisbon Valley mineral claims. The purpose of the unitization is to eliminate property boundaries,

DelMar Pharmaceuticals Provides VAL-083 Updates from the Ongoing American Association for Cancer Research (AACR) Annual Meeting

DelMar Pharmaceuticals Provides VAL-083 Updates from the Ongoing American Association for Cancer Research (AACR) Annual Meeting

DelMar Pharmaceuticals (NASDAQ:DMPI), a biopharmaceutical company focused on the development and commercialization of new cancer therapies, today announced that it has presented three abstracts at the American Association for Cancer Research (AACR) Annual Meeting. These abstracts are all focused on pre-clinical research to elucidate the mechanism of action (MOA) of

MGX Minerals Files Q2 Results, No Details in NR

MGX Minerals Files Q2 Results, No Details in NR

MGX Minerals (CSE:XMG) has filed an annual information form with Canadian securities authorities. MGX has also filed its unaudited interim financial statements for the three and six months ended January 31, 2017 and 2016, together with accompanying management’s discussion and analysis.

Recapitalization of Black Dragon Gold

Recapitalization of Black Dragon Gold

As previously announced, management has been focused on recapitalizing the Company in such a way as to bring long term value and liquidity to the Company’s shareholders. The Company explored debt and hybrid instruments, however the requirement for repayment of an existing facility (which has been renegotiated to US$3.2 million)

Laguna Blends Announces the Addition of Marcos Agramont as Chief Operating Officer

Laguna Blends Announces the Addition of Marcos Agramont as Chief Operating Officer

Laguna Blends  (CSE:LAG) (OTC Pink: LAGBF) (FSE: LB6A) (the “Company” or “Laguna”)

is pleased to announce that it has appointed Marcos Agramont as its Chief Operating Officer (COO) effective immediately.

Mr. Agramont has been a leading innovator in the Cannabis Industry for the last five years developing products for domestic and international channels. He

DelMar Pharmaceuticals Announces Abstract Presentations for the American Association for Cancer Research (AACR) Annual Meeting in April 2017

DelMar Pharmaceuticals Announces Abstract Presentations for the American Association for Cancer Research (AACR) Annual Meeting in April 2017

DelMar Pharmaceuticals (NASDAQ:DMPI), a biopharmaceutical company focused on the development and commercialization of new cancer therapies, today announced that it will present three abstracts at the American Association of Cancer Research (AACR) Annual Meeting. The abstracts are based on research conducted with DelMar’s lead anti-cancer product candidate, VAL-083 (dianhydrogalactitol), a

Enter Your Log In Credentials
×

Privacy & Legal Policy

Privacy Policy

×
Investing News Network